Atropine Dosing in Pediatric Patients

Standard Dosing by Clinical Indication

• The American Heart Association recommends atropine 0.02 mg/kg IV/IO for symptomatic bradycardia in children, with a minimum single dose of 0.1 mg and maximum single dose of 0.5 mg for children, which can be repeated every 5 minutes up to a maximum total dose of 1 mg for children and 2 mg for adolescents 1, 2
• For symptomatic bradycardia, the initial dose is 0.02 mg/kg IV/IO, with a minimum single dose of 0.1 mg for children 1, 2
• The maximum single dose for children is 0.5 mg and for adolescents is 1.0 mg 1, 2
• Atropine can be repeated every 5 minutes as needed, with a maximum total dose of 1 mg for children and 2 mg for adolescents 1
• The American Heart Association emphasizes that oxygenation and ventilation are essential first maneuvers before considering atropine, as hypoxia-induced bradycardia typically responds to these interventions alone 1

Rapid Sequence Intubation (RSI) Premedication

• The dose for RSI premedication is 0.01-0.02 mg/kg IV/IO, administered before sedative/anesthetic and paralytic agents 1

Anticholinesterase/Organophosphate Poisoning

• The initial dose for anticholinesterase/organophosphate poisoning is 0.02-0.05 mg/kg IV, with a maximum single dose of 2-3 mg, and can be repeated as needed for clinical effect based on muscarinic symptoms 1, 3
• For nerve agent intoxication, the initial dose should be 0.02 mg/kg for children, and cumulative doses may need to be substantially higher 4
• The American Society of Anesthesiologists notes that adult patients may require 10-20 mg in the first 2-3 hours, and up to 50 mg in 24 hours before full muscarinic antagonism appears 4
• Atropine must be combined with oximes (pralidoxime) to address nicotinic receptor dysfunction and respiratory muscle paralysis, as atropine alone has minimal effect on these symptoms 3, 4

Alternative Routes When IV/IO Access Unavailable

• For endotracheal administration, the dose is 0.01-0.03 mg/kg for neonates and 0.03-0.06 mg/kg for children and adolescents, followed by or diluted in saline flush (1-5 mL) based on patient size 1

Critical Safety Considerations

• Atropine sulfate comes in different concentrations, and dosage should be calculated carefully to avoid 10-fold errors, which are common with pediatric dosing 1
• Atropine should be administered by slow IV push for cardiac arrest to avoid paradoxical bradycardia 2
• Monitor heart rate and blood pressure continuously during and after administration, and observe for reversal of bradycardia within 3 minutes (peak action time) 1, 2
• Watch for tachycardia, which could worsen ischemia in patients with underlying cardiac conditions 1, 2

Common Pitfalls to Avoid

• Do not routinely use atropine for RSI premedication in all pediatric patients, as it may be unnecessary for many patients 1
• Do not use atropine for type II second-degree AV block or third-degree AV block with wide-complex escape rhythm, as it is ineffective and potentially harmful in these conditions 2
• Do not withhold adequate atropine doses in organophosphate poisoning due to fear of overdose, as inadequate dosing can be fatal 3, 4

Atropine Dosing Guidelines for Pediatric Patients

1. Symptomatic Bradycardia and AV Block

2. Organophosphate or Carbamate Poisoning

3. Rapid Sequence Intubation (RSI) Premedication

4. Neonatal Dosing Considerations

5. Alternative Routes When IV/IO Access Is Unavailable

All dosing recommendations above are derived from the cited sources【5】.

6. Safety Considerations

Atropine Dosing Transition Criteria for Children and Adolescents

Weight‑Based Threshold

• Children whose body weight exceeds 40 kg should be treated with adult atropine dosing regimens (adult maximum single dose of 1 mg) rather than pediatric dosing, irrespective of chronological age. 7

Age‑Based Threshold

• Initiation of adult atropine dosing is appropriate at approximately 12–15 years of age, aligning with the transition from pediatric to adolescent dosing recommendations. 7

Pharmacokinetic Rationale for the 40 kg Cut‑off

• The 40 kg weight mark corresponds to the point where absolute (fixed) dosing becomes more suitable than weight‑adjusted dosing because pharmacokinetic parameters in children above this weight approximate adult values. 7

Practical Dosing Example for Larger Children

• An adolescent weighing more than 40 kg should receive the adult maximum single dose of 1 mg and a cumulative maximum dose of 2 mg for symptomatic bradycardia, rather than the pediatric limits of 0.5 mg single and 1 mg total. 7

Atropine Dosing Guidelines (Cited Evidence)

Symptomatic Bradycardia and Atrioventricular Block in Children

Evidence from Circulation (2010)

• Initial dose: 0.02 mg/kg administered intravenously (IV) or intra‑osseously (IO).
• Minimum single dose: 0.1 mg to avoid paradoxical bradycardia.
• Maximum single dose: 0.5 mg for children; 1 mg for adolescents.
• Repeat interval: Every 5 minutes as needed, up to a maximum total dose of 1 mg in children and 2 mg in adolescents.
• Strength of evidence: Not explicitly graded in the source.

8, 9

Endotracheal (ET) Administration When IV/IO Access Is Unavailable

Evidence from Circulation (2010)

• The ET dose is 2–3 times the IV/IO dose to compensate for lower pulmonary absorption.
• During cardiopulmonary resuscitation, briefly pause chest compressions, give the ET dose, flush, and deliver the ventilations.

8, 9

Anticholinesterase (Organophosphate/Carbamate) Poisoning

Evidence from Circulation (2023)

• Loading dose: 0.02 – 0.05 mg/kg IV (maximum single dose 2–3 mg).
• Escalation: If clinical response is inadequate, double the dose every 10–20 minutes until full atropinization is achieved.
• Therapeutic endpoints indicating adequate atropinization:
• Maintenance infusion: After bolus dosing, infuse 10–20 % of the total loading dose per hour (up to 2 mg/h in adults).
• Adjunctive therapy: Combine atropine with pralidoxime (oxime) to reverse nicotinic effects and add benzodiazepines for seizure control.

10